These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 30476962)

  • 1. Diagnosis and Management of Nonalcoholic Fatty Liver Disease.
    Paul S; Davis AM
    JAMA; 2018 Dec; 320(23):2474-2475. PubMed ID: 30476962
    [No Abstract]   [Full Text] [Related]  

  • 2. Non-alcoholic fatty liver disease (NAFLD): summary of NICE guidance.
    Glen J; Floros L; Day C; Pryke R;
    BMJ; 2016 Sep; 354():i4428. PubMed ID: 27605111
    [No Abstract]   [Full Text] [Related]  

  • 3. Guidelines of prevention and treatment of nonalcoholic fatty liver disease (2018, China).
    Fan JG; Wei L; Zhuang H;
    J Dig Dis; 2019 Apr; 20(4):163-173. PubMed ID: 30444584
    [No Abstract]   [Full Text] [Related]  

  • 4. Metabolic Syndrome: Nonalcoholic Fatty Liver Disease.
    Williams T
    FP Essent; 2015 Aug; 435():24-9. PubMed ID: 26280342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A REVIEW OF INTERNATIONAL AND NATIONAL CLINICAL GUIDELINES FOR THE DIAGNOSIS AND TREATMENT-OF NONALCOHOLIC FATTY LIVER DISEASE.
    Golovanova EV; Lazebnik LB
    Eksp Klin Gastroenterol; 2016; (11):76-83. PubMed ID: 29889450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonalcoholic fatty liver disease: diagnosis, pathogenesis, and management.
    Başaranoğlu M; Örmeci N
    Turk J Gastroenterol; 2014 Apr; 25(2):127-32. PubMed ID: 25003670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonalcoholic Fatty Liver Disease.
    Am Fam Physician; 2020 Nov; 102(10):Online. PubMed ID: 33179900
    [No Abstract]   [Full Text] [Related]  

  • 8. Management and diagnosis of fatty liver disease.
    Schneier AT; Citti CC; Dieterich DT
    Expert Rev Gastroenterol Hepatol; 2015 May; 9(5):671-83. PubMed ID: 25716275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Editorial: Non-alcoholic Fatty Liver Disease and Non-alcoholic Steatohepatitis: An Epidemic that will Boost the Incidence of Cardiovascular Morbidity and Mortality.
    Athyros VG; Doumas M
    Curr Vasc Pharmacol; 2018; 16(3):206-208. PubMed ID: 29598814
    [No Abstract]   [Full Text] [Related]  

  • 10. Hot Topics in Primary Care: Diagnosis of Cirrhosis and Evaluation of Hepatic Encephalopathy: Common Errors and Their Significance for the PCP.
    Flamm SL
    J Fam Pract; 2017 Apr; 66(4 Suppl):S34-S39. PubMed ID: 28375406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Implications for liver transplantation.
    Younossi ZM
    Liver Transpl; 2018 Feb; 24(2):166-170. PubMed ID: 29272073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [An interpretation of European guidelines for the diagnosis and treatment of nonalcoholic fatty liver disease].
    Xin FZ; Fan JG
    Zhonghua Gan Zang Bing Za Zhi; 2016 Jun; 24(6):403-5. PubMed ID: 27465941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [An interpretation of the AASLD practice guideline on the diagnosis and management of nonalcoholic fatty liver disease in 2017].
    Nan YM; Fu N; Li WC; Kong LL; Yuan XW; Zhang SY; Liu LD; Lu Y; Cui LY
    Zhonghua Gan Zang Bing Za Zhi; 2017 Sep; 25(9):687-694. PubMed ID: 29108191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Under-prescription of statins in patients with non-alcoholic fatty liver disease.
    Del Ben M; Baratta F; Polimeni L; Pastori D; Loffredo L; Averna M; Violi F; Angelico F
    Nutr Metab Cardiovasc Dis; 2017 Feb; 27(2):161-167. PubMed ID: 27914698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How to Approach a Patient With Nonalcoholic Fatty Liver Disease.
    Tilg H
    Gastroenterology; 2017 Aug; 153(2):345-349. PubMed ID: 28647352
    [No Abstract]   [Full Text] [Related]  

  • 16. Statins Are Underutilized in Patients with Nonalcoholic Fatty Liver Disease and Dyslipidemia.
    Blais P; Lin M; Kramer JR; El-Serag HB; Kanwal F
    Dig Dis Sci; 2016 Jun; 61(6):1714-20. PubMed ID: 26707137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Editorial: Recent News on Statins for the Treatment of Non-Alcoholic Fatty Liver Disease/Non-Alcoholic Steatohepatitis.
    Athyros VG; Katsiki N; Doumas M
    Curr Vasc Pharmacol; 2018 Jan; 16(2):104-106. PubMed ID: 29210655
    [No Abstract]   [Full Text] [Related]  

  • 18. Nonalcoholic Fatty Liver Disease.
    Sweet PH; Khoo T; Nguyen S
    Prim Care; 2017 Dec; 44(4):599-607. PubMed ID: 29132522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Future of Nonalcoholic Fatty Liver Disease Treatment.
    Mazhar K
    Med Clin North Am; 2019 Jan; 103(1):57-69. PubMed ID: 30466676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular risk across the histological spectrum and the clinical manifestations of non-alcoholic fatty liver disease: An update.
    Athyros VG; Tziomalos K; Katsiki N; Doumas M; Karagiannis A; Mikhailidis DP
    World J Gastroenterol; 2015 Jun; 21(22):6820-34. PubMed ID: 26078558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.